NHS England and NHS Improvement open call for innovation in cancer diagnosis

Following the success from the first call launched last year, NHS England and NHS Improvement are delighted to announce a £15 million funding competition for innovation to go to the open market in the field of cancer.

This competition invites applications for funding to implement solutions in late-stage development into front-line settings to improve early detection and diagnosis of cancer.

The NHS Cancer Programme at NHS England and NHS Improvement (NHSEI) are looking for innovations or new approaches that will increase the proportion of cancers that are diagnosed at stage one or two.

The competition is open to all types of innovations, including but not limited to, medical devices, in-vitro diagnostics, digital health solutions, behavioural interventions, software, artificial intelligence or new models of care. Innovations can be tumour specific or multi-cancer. Applications from multicancer innovations which could have a bigger impact on early diagnosis rates are particularly welcome.

This competition is developed and led by the NHS Cancer Programme and it is supported by the Small Business Research Initiative (SBRI) Healthcare Programme and the NHS Accelerated Access Collaborative (AAC). The call is open to any innovation with proven efficacy and clinical effectiveness, which meets the following requirements:

• CE mark or equivalent regulatory approval obtained (if required for your innovation), and /or

• in use in at least 1 Trust in standard routine care (non-research)

The aim of this programme is to accelerate these innovations into front-line clinical settings by shortening the gap between the evidence collated from traditional safety/efficacy clinical trials typically required for regulatory approvals (CE marking or equivalent), and the evidence required by commissioners to make purchasing decisions.

In the first instance, projects may request for a maximum of 18 months and up to £4M (excl VAT). Please ensure the proposed project deliverables could be reasonably achieved within the suggested contract duration, and all requested costs be justified.

All applications must be made using the application portal, which can be accessed through the Research Management System. The form must be completed and submitted electronically through the online application portal.

Only applications received by 1:00pm GMT on 24 May 2022 will be accepted.

For more information, documentation and the link to the application portal, please visit the Competition Website: https://sbrihealthcare.co.uk/competition/nhs-cancer-programme-competition-2/

Key dates

Competition launch: 05 April 2022

Deadline for applications: 24 May 2022, 1pm

Assessment: May/June 2022

Interview Panel: Mid-September 2022

Contracts awarded: October 202